Thread‐based microfluidic chips as a platform to assess acetylcholinesterase activity

• Published in: Electrophoresis Vol. 38; no. 7; pp. 996 - 1001
• Main Authors: Gonzalez, Ariana, Gaines, Michelle, Gomez, Frank A.
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.04.2017
• Subjects: Acetylcholinesterase; Acetylcholinesterase - analysis; Acetylcholinesterase - drug effects; Acetylcholinesterase - metabolism; Animals; Assay; Channels; Chips; Cholinesterase Inhibitors - pharmacology; Color; Colorimetry; Cysteine; Data acquisition; Devices; Diagnostic systems; Dinitrobenzenes - analysis; Dinitrobenzenes - metabolism; Electrophoresis; Electrophorus; Equipment Design; Inlets; Microfluidic Analytical Techniques - instrumentation; Microfluidic Analytical Techniques - methods; Microfluidics; Multiplexing; Neostigmine - pharmacology; Nitrobenzoic acid; Nylons; Nylons - chemistry; Paper microfluidics; Platforms; Assay; Acetylcholinesterase; Paper microfluidics
• ISSN: 0173-0835; 1522-2683
• DOI: 10.1002/elps.201600476

In this paper, a microfluidic thread‐based analytical device (μTAD) to assess the activity of acetylcholinesterase (AChE) via colorimetric analylsis is described. Fabrication of the device consists of two platforms, both with a nylon thread trifurcated into three channels terminating at open analysis sites at the end of the thread. 5,5’‐Dithiobis‐(2‐nitrobenzoic acid) (DTNB) was spotted and dried on the analysis sites. Acetylthiocholine iodide (ATC) (or cysteine, Cys) is transported through an inlet channel of the nylon thread by capillary action due to the hydrophilic nature of nylon. AChE is transported through the other inlet channel and mixes with the ATC (or Cys) as they travel up to the analysis sites. As the solution reaches the analysis sites, an intense yellow color change occurs indicating the reaction of the thiol with DTNB to produce the yellow anion TNB2−. The sites are then dried, scanned, yielding a linear range of inverse yellow mean intensity versus substrate concentration. An IC50 value (1.74 nM) with a known inhibitor, neostigmine bromide (NB), is obtained on the device. The multiplex design enables triplicate data collection in a device that is easy to use. μTADs have great potential to be employed in a myriad of tests including point‐of‐care diagnostic devices for resource‐challenged settings.